特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
934761

制限エンドヌクレアーゼの世界市場:2025年までの予測と市場機会

Global Restriction Endonuclease Market By Type, By Application, By End Type, By Source, By Cleavage Specificity, By End-User, By Region, Competition, Forecast & Opportunities, 2025

出版日: | 発行: TechSci Research | ページ情報: 英文 116 Pages | 納期: お問合せ

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

制限エンドヌクレアーゼの世界市場:2025年までの予測と市場機会
出版日: 2020年05月01日
発行: TechSci Research
ページ情報: 英文 116 Pages
納期: お問合せ
  • 全表示
  • 概要
  • 目次
概要

世界の制限エンドヌクレアーゼ市場は予測期間中に堅牢なCAGRで成長する予定です。市場の成長の主な要因は、バイオテクノロジーセクターや製薬業界などの最終用途業界での研究開発活動への投資の増加です。さらに、糖尿病、がんなどの慢性的な健康障害の発生率の上昇は、今後数年間で世界中の制限エンドヌクレアーゼ市場の成長の前兆となることが予想されます。

当レポートは、世界の制限エンドヌクレアーゼ市場をセグメント別や地域別で調査したもので、市場規模および市場シェアの予測、促進要因と課題、市場動向、競合情勢、企業プロファイルなどの情報を提供しています。

目次

第1章 製品の概要

第2章 調査手法

第3章 世界の制限エンドヌクレアーゼ市場に対するCOVID-19の影響

第4章 エグゼクティブサマリー

第5章 世界の制限エンドヌクレアーゼ市場の展望

  • 市場規模と予測
  • 市場シェアと予測
    • タイプ別(I、II、III、IV)
    • 用途別(遺伝子工学、DNAマッピング、遺伝子配列決定など)
    • エンドタイプ別(スティッキーエンド、ブラントエンド)
    • ソース別(細菌、古細菌)
    • 切断特異性別(イソシゾマー、ネオシゾマー)
    • エンドユーザー別(製薬およびバイオテクノロジー企業、学術調査機関など)
    • 会社別(2019年)
    • 地域別
  • 市場魅力指数

第6章 アジア太平洋の制限エンドヌクレアーゼ市場の展望

  • 市場規模と予測
  • 市場シェアと予測
    • タイプ別
    • 用途別
    • エンドタイプ別
    • ソース別
    • 切断特異性別
    • エンドユーザー別
    • 国別
  • 市場魅力指数
  • アジア太平洋:国分析
    • 中国
    • インド
    • 日本
    • 韓国
    • シンガポール
    • オーストラリア

第7章 欧州の制限エンドヌクレアーゼ市場の展望

  • 市場規模と予測
  • 市場シェアと予測
    • タイプ別
    • 用途別
    • エンドタイプ別
    • ソース別
    • 切断特異性別
    • エンドユーザー別
    • 国別
  • 市場魅力指数
  • 欧州:国分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 北米の制限エンドヌクレアーゼ市場の展望

  • 市場規模と予測
  • 市場シェアと予測
    • タイプ別
    • 用途別
    • エンドタイプ別
    • ソース別
    • 切断特異性別
    • エンドユーザー別
    • 国別
  • 市場魅力指数
  • 北米:国分析
    • 米国
    • メキシコ
    • カナダ

第9章 南米の制限エンドヌクレアーゼ市場の展望

  • 市場規模と予測
  • 市場シェアと予測
    • タイプ別
    • 用途別
    • エンドタイプ別
    • ソース別
    • 切断特異性別
    • エンドユーザー別
    • 国別
  • 市場魅力指数
  • 南米:国分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの制限エンドヌクレアーゼ市場の展望

  • 市場規模と予測
  • 市場シェアと予測
    • タイプ別
    • 用途別
    • エンドタイプ別
    • ソース別
    • 切断特異性別
    • エンドユーザー別
    • 国別
  • 市場魅力指数
  • 中東・アフリカ:国分析
    • 南アフリカ
    • サウジアラビア
    • UAE

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

第13章 競合情勢

  • 競合の展望
  • 主要企業プロファイル
    • New England Biolabs
    • Thermo Fisher Scientific
    • Takara Bio
    • Sigma-Aldrich
    • Illumina
    • Agilent Technologies
    • Promega
    • Jena Biosciences
    • Genetix Biotech Asia Pvt. Ltd.
    • Roche
    • Merck
    • Pfizer
    • Amgen
    • Vertex Pharmaceuticals
    • BioMarin Pharmaceutical
    • PerkinElmer
    • Abcam
    • Abbexa
    • Sisco Research Laboratories Pvt Ltd
    • Nippon Gene

第14章 戦略的推奨事項

第15章 免責事項について

目次
Product Code: 4638

Global restriction endonuclease market is expected to grow at a formidable CAGR during the forecast period. The key factor responsible for market growth is growing investment in research and development activities in end use industries such as biotechnology sector and pharmaceutical industry. Additionally, rising incidences of chronic health disorders like diabetes, cancer among others is anticipated to bode well for the growth of restriction endonuclease market across the globe in the coming years. Moreover, increasing government support in terms of providing funds is projected to bolster the market growth through 2025.

The global restriction endonuclease market is segmented based on type, application, end type, source, cleavage, end-user, region and company. Based on type, the market can be segmented into Type I, Type II, Type III and Type IV. Out of which, the Type II segment dominated the market in terms of largest market size until 2019 and is further anticipated to maintain its lead during the forecast years as well. This growth can be accredited to its use in molecular biology applications that are carried on everyday such as gene cloning and DNA fragmentation and analysis. Also, because these enzymes cleave DNA at fixed positions, therefore small, well-defined fragments of DNA are produced which assist in characterization of genes and genomes, thereby anticipated to boost the growth of Type II restriction endonucleases segment over the coming years. Moreover, increasing investments in development activities by biotechnology companies is further aiding the segmental growth.

Major players operating in the global restriction endonuclease market include New England Biolabs, Thermo Fisher Scientific, Takara Bio, Sigma-Aldrich, Illumina, Agilent Technologies, Promega, Jena Biosciences, Genetix Biotech Asia Pvt. Ltd., Roche, Merck, Pfizer, Amgen, Vertex Pharmaceuticals, BioMarin Pharmaceutical, PerkinElmer, Abcam, Abbexa, Sisco Research Laboratories Pvt Ltd, Nippon Gene. The companies operating in restriction endonuclease market across the globe are focussing more towards the expanding their share in the market. For instance, these key players are making organic strategies such as developing novel technologies in order to meet the requirements of users and to make the industry highly competitive.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyse and forecast the market size of global restriction endonuclease market.
  • To classify and forecast global restriction endonuclease market based on type, application, end type, source, cleavage, end-user, company and regional distribution.
  • To identify drivers and challenges for global restriction endonuclease market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global restriction endonuclease market.
  • To conduct pricing analysis for global restriction endonuclease market.
  • To identify and analyse the profile of leading players operating in global restriction endonuclease market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of companies across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies which could not be identified due to the limitations of secondary research. TechSci Research analyzed the new products, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global restriction endonuclease market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Restriction endonuclease companies and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to restriction endonuclease
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as companies and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global restriction endonuclease market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Type:

Type I

Type II

Type III

Type IV

  • Market, By Application:

Genetic Engineering

DNA Mapping

Gene Sequencing

Others

  • Market, By End Type:

Sticky End

Blunt End

  • Market, By Source:

Bacteria

Archaea

  • Market, By Cleavage Specificity:

Isoschizomers

Neoschizomers

  • Market, By End-User:

Pharmaceutical and Biotechnology Companies

Academic Research Institutes

Others

  • Market, By Region:

North America

  • United States
  • Mexico
  • Canada

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Singapore

Middle East and Africa

  • South Africa
  • Saudi Arabia
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global restriction endonuclease market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Restriction Endonuclease Market

4. Executive Summary

5. Global Restriction Endonuclease Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value & Volume
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (I, II, III, IV)
    • 5.2.2. By Application ( Genetic Engineering, DNA Mapping, Gene Sequencing and Others)
    • 5.2.3. By End Type (Sticky End, Blunt End)
    • 5.2.4. By Source (Bacteria, Archaea)
    • 5.2.5. By Cleavage Specificity (Isoschizomers, Neoschizomers)
    • 5.2.6. By End-User (Pharmaceutical and Biotechnology Companies, Academic Research Institutes and Others)
    • 5.2.7. By Company (2019)
    • 5.2.8. By Region
  • 5.3. Market Attractiveness Index

6. Asia-Pacific Restriction Endonuclease Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By End Type
    • 6.2.4. By Source
    • 6.2.5. By Cleavage Specificity
    • 6.2.6. By End-User
    • 6.2.7. By Country
  • 6.3. Market Attractiveness Index
  • 6.4. Asia-Pacific: Country Analysis
    • 6.4.1. China Restriction Endonuclease Market Outlook
      • 6.4.1.1. Market Size & Forecast
        • 6.4.1.1.1. By Value
      • 6.4.1.2. Market Share & Forecast
        • 6.4.1.2.1. By Type
        • 6.4.1.2.2. By Application
        • 6.4.1.2.3. By End Type
        • 6.4.1.2.4. By Source
        • 6.4.1.2.5. By Cleavage Specificity
        • 6.4.1.2.6. By End-User
    • 6.4.2. India Restriction Endonuclease Market Outlook
      • 6.4.2.1. Market Size & Forecast
        • 6.4.2.1.1. By Value
      • 6.4.2.2. Market Share & Forecast
        • 6.4.2.2.1. By Type
        • 6.4.2.2.2. By Application
        • 6.4.2.2.3. By End Type
        • 6.4.2.2.4. By Source
        • 6.4.2.2.5. By Cleavage Specificity
        • 6.4.2.2.6. By End-User
    • 6.4.3. Japan Restriction Endonuclease Market Outlook
      • 6.4.3.1. Market Size & Forecast
        • 6.4.3.1.1. By Value
      • 6.4.3.2. Market Share & Forecast
        • 6.4.3.2.1. By Type
        • 6.4.3.2.2. By Application
        • 6.4.3.2.3. By End Type
        • 6.4.3.2.4. By Source
        • 6.4.3.2.5. By Cleavage Specificity
        • 6.4.3.2.6. By End-User
    • 6.4.4. South Korea Restriction Endonuclease Market Outlook
      • 6.4.4.1. Market Size & Forecast
        • 6.4.4.1.1. By Value
      • 6.4.4.2. Market Share & Forecast
        • 6.4.4.2.1. By Type
        • 6.4.4.2.2. By Application
        • 6.4.4.2.3. By End Type
        • 6.4.4.2.4. By Source
        • 6.4.4.2.5. By Cleavage Specificity
        • 6.4.4.2.6. By End-User
    • 6.4.5. Singapore Restriction Endonuclease Market Outlook
      • 6.4.5.1. Market Size & Forecast
        • 6.4.5.1.1. By Value
      • 6.4.5.2. Market Share & Forecast
        • 6.4.5.2.1. By Type
        • 6.4.5.2.2. By Application
        • 6.4.5.2.3. By End Type
        • 6.4.5.2.4. By Source
        • 6.4.5.2.5. By Cleavage Specificity
        • 6.4.5.2.6. By End-User
    • 6.4.6. Australia Restriction Endonuclease Market Outlook
      • 6.4.6.1. Market Size & Forecast
        • 6.4.6.1.1. By Value
      • 6.4.6.2. Market Share & Forecast
        • 6.4.6.2.1. By Type
        • 6.4.6.2.2. By Application
        • 6.4.6.2.3. By End Type
        • 6.4.6.2.4. By Source
        • 6.4.6.2.5. By Cleavage Specificity
        • 6.4.6.2.6. By End-User

7. Europe Restriction Endonuclease Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By End Type
    • 7.2.4. By Source
    • 7.2.5. By Cleavage Specificity
    • 7.2.6. By End-User
    • 7.2.7. By Country
  • 7.3. Market Attractiveness Index
  • 7.4. Europe: Country Analysis
    • 7.4.1. France Restriction Endonuclease Market Outlook
      • 7.4.1.1. Market Size & Forecast
        • 7.4.1.1.1. By Value
      • 7.4.1.2. Market Share & Forecast
        • 7.4.1.2.1. By Type
        • 7.4.1.2.2. By Application
        • 7.4.1.2.3. By End Type
        • 7.4.1.2.4. By Source
        • 7.4.1.2.5. By Cleavage Specificity
        • 7.4.1.2.6. By End-User
    • 7.4.2. Germany Restriction Endonuclease Market Outlook
      • 7.4.2.1. Market Size & Forecast
        • 7.4.2.1.1. By Value
      • 7.4.2.2. Market Share & Forecast
        • 7.4.2.2.1. By Type
        • 7.4.2.2.2. By Application
        • 7.4.2.2.3. By End Type
        • 7.4.2.2.4. By Source
        • 7.4.2.2.5. By Cleavage Specificity
        • 7.4.2.2.6. By End-User
    • 7.4.3. United Kingdom Restriction Endonuclease Market Outlook
      • 7.4.3.1. Market Size & Forecast
        • 7.4.3.1.1. By Value
      • 7.4.3.2. Market Share & Forecast
        • 7.4.3.2.1. By Type
        • 7.4.3.2.2. By Application
        • 7.4.3.2.3. By End Type
        • 7.4.3.2.4. By Source
        • 7.4.3.2.5. By Cleavage Specificity
        • 7.4.3.2.6. By End-User
    • 7.4.4. Italy Restriction Endonuclease Market Outlook
      • 7.4.4.1. Market Size & Forecast
        • 7.4.4.1.1. By Value
      • 7.4.4.2. Market Share & Forecast
        • 7.4.4.2.1. By Type
        • 7.4.4.2.2. By Application
        • 7.4.4.2.3. By End Type
        • 7.4.4.2.4. By Source
        • 7.4.4.2.5. By Cleavage Specificity
        • 7.4.4.2.6. By End-User
    • 7.4.5. Spain Restriction Endonuclease Market Outlook
      • 7.4.5.1. Market Size & Forecast
        • 7.4.5.1.1. By Value
      • 7.4.5.2. Market Share & Forecast
        • 7.4.5.2.1. By Type
        • 7.4.5.2.2. By Application
        • 7.4.5.2.3. By End Type
        • 7.4.5.2.4. By Source
        • 7.4.5.2.5. By Cleavage Specificity
        • 7.4.5.2.6. By End-User

8. North America Restriction Endonuclease Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By End Type
    • 8.2.4. By Source
    • 8.2.5. By Cleavage Specificity
    • 8.2.6. By End-User
    • 8.2.7. By Country
  • 8.3. Market Attractiveness Index
  • 8.4. North America: Country Analysis
    • 8.4.1. United States Restriction Endonuclease Market Outlook
      • 8.4.1.1. Market Size & Forecast
        • 8.4.1.1.1. By Value
      • 8.4.1.2. Market Share & Forecast
        • 8.4.1.2.1. By Type
        • 8.4.1.2.2. By Application
        • 8.4.1.2.3. By End Type
        • 8.4.1.2.4. By Source
        • 8.4.1.2.5. By Cleavage Specificity
        • 8.4.1.2.6. By End-User
    • 8.4.2. Mexico Restriction Endonuclease Market Outlook
      • 8.4.2.1. Market Size & Forecast
        • 8.4.2.1.1. By Value
      • 8.4.2.2. Market Share & Forecast
        • 8.4.2.2.1. By Type
        • 8.4.2.2.2. By Application
        • 8.4.2.2.3. By End Type
        • 8.4.2.2.4. By Source
        • 8.4.2.2.5. By Cleavage Specificity
        • 8.4.2.2.6. By End-User
    • 8.4.3. Canada Restriction Endonuclease Market Outlook
      • 8.4.3.1. Market Size & Forecast
        • 8.4.3.1.1. By Value
      • 8.4.3.2. Market Share & Forecast
        • 8.4.3.2.1. By Type
        • 8.4.3.2.2. By Application
        • 8.4.3.2.3. By End Type
        • 8.4.3.2.4. By Source
        • 8.4.3.2.5. By Cleavage Specificity
        • 8.4.3.2.6. By End-User

9. South America Restriction Endonuclease Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By End Type
    • 9.2.4. By Source
    • 9.2.5. By Cleavage Specificity
    • 9.2.6. By End-User
    • 9.2.7. By Country
  • 9.3. Market Attractiveness Index
  • 9.4. South America: Country Analysis
    • 9.4.1. Brazil Restriction Endonuclease Market Outlook
      • 9.4.1.1. Market Size & Forecast
        • 9.4.1.1.1. By Value
      • 9.4.1.2. Market Share & Forecast
        • 9.4.1.2.1. By Type
        • 9.4.1.2.2. By Application
        • 9.4.1.2.3. By End Type
        • 9.4.1.2.4. By Source
        • 9.4.1.2.5. By Cleavage Specificity
        • 9.4.1.2.6. By End-User
    • 9.4.2. Argentina Restriction Endonuclease Market Outlook
      • 9.4.2.1. Market Size & Forecast
        • 9.4.2.1.1. By Value
      • 9.4.2.2. Market Share & Forecast
        • 9.4.2.2.1. By Type
        • 9.4.2.2.2. By Application
        • 9.4.2.2.3. By End Type
        • 9.4.2.2.4. By Source
        • 9.4.2.2.5. By Cleavage Specificity
        • 9.4.2.2.6. By End-User
    • 9.4.3. Colombia Restriction Endonuclease Market Outlook
      • 9.4.3.1. Market Size & Forecast
        • 9.4.3.1.1. By Value
      • 9.4.3.2. Market Share & Forecast
        • 9.4.3.2.1. By Type
        • 9.4.3.2.2. By Application
        • 9.4.3.2.3. By End Type
        • 9.4.3.2.4. By Source
        • 9.4.3.2.5. By Cleavage Specificity
        • 9.4.3.2.6. By End-User

10. Middle East and Africa Restriction Endonuclease Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By End Type
    • 10.2.4. By Source
    • 10.2.5. By Cleavage Specificity
    • 10.2.6. By End-User
    • 10.2.7. By Country
  • 10.3. Market Attractiveness Index
  • 10.4. MEA: Country Analysis
    • 10.4.1. South Africa Restriction Endonuclease Market Outlook
      • 10.4.1.1. Market Size & Forecast
        • 10.4.1.1.1. By Value
      • 10.4.1.2. Market Share & Forecast
        • 10.4.1.2.1. By Type
        • 10.4.1.2.2. By Application
        • 10.4.1.2.3. By End Type
        • 10.4.1.2.4. By Source
        • 10.4.1.2.5. By Cleavage Specificity
        • 10.4.1.2.6. By End-User
    • 10.4.2. Saudi Arabia Restriction Endonuclease Market Outlook
      • 10.4.2.1. Market Size & Forecast
        • 10.4.2.1.1. By Value
      • 10.4.2.2. Market Share & Forecast
        • 10.4.2.2.1. By Type
        • 10.4.2.2.2. By Application
        • 10.4.2.2.3. By End Type
        • 10.4.2.2.4. By Source
        • 10.4.2.2.5. By Cleavage Specificity
        • 10.4.2.2.6. By End-User
    • 10.4.3. UAE Restriction Endonuclease Market Outlook
      • 10.4.3.1. Market Size & Forecast
        • 10.4.3.1.1. By Value
      • 10.4.3.2. Market Share & Forecast
        • 10.4.3.2.1. By Type
        • 10.4.3.2.2. By Application
        • 10.4.3.2.3. By End Type
        • 10.4.3.2.4. By Source
        • 10.4.3.2.5. By Cleavage Specificity
        • 10.4.3.2.6. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

13. Competitive Landscape

  • 13.1. Competition Outlook
  • 13.2. Players Profiled (Leading Companies)
    • 13.2.1. New England Biolabs
    • 13.2.2. Thermo Fisher Scientific
    • 13.2.3. Takara Bio
    • 13.2.4. Sigma-Aldrich
    • 13.2.5. Illumina
    • 13.2.6. Agilent Technologies
    • 13.2.7. Promega
    • 13.2.8. Jena Biosciences
    • 13.2.9. Genetix Biotech Asia Pvt. Ltd.
    • 13.2.10. Roche
    • 13.2.11. Merck
    • 13.2.12. Pfizer
    • 13.2.13. Amgen
    • 13.2.14. Vertex Pharmaceuticals
    • 13.2.15. BioMarin Pharmaceutical
    • 13.2.16. PerkinElmer
    • 13.2.17. Abcam
    • 13.2.18. Abbexa
    • 13.2.19. Sisco Research Laboratories Pvt Ltd
    • 13.2.20. Nippon Gene

14. Strategic Recommendations

15. About Us & Disclaimer

株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.